Xiaoli Liu, Ph.D.
Affiliations: | 2010 | Pennsylvania State University, State College, PA, United States |
Google:
"Xiaoli Liu"Mean distance: 22.47 (cluster 32)
Parents
Sign in to add mentor| James Connor | grad student | 2010 | Penn State | |
| (Heavy chain ferritin siRNA delivered by cationic liposomes enhances radiation and chemotherapeutic efficacy for treatment of glioma.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Madhankumar A, Webb B, Mrowczynski O, et al. (2017) SCDT-50. SURFACE MODIFIED LIPOSOMES FOR EFFECTIVE DELIVERY OF THERAPEUTIC AGENTS ACROSS THE BLOOD BRAIN BARRIER Neuro-Oncology. 19: vi274-vi275 |
| Liu X, Madhankumar A, Miller P, et al. (2016) DDIS-14. TARGETED LIPOSOMES WITH GADOLINIUM ARE MORE SENSITIVE AND MORE SPECIFIC FOR TUMOR DETECTION THAN MAGNEVIST Neuro-Oncology. 18: vi50-vi50 |
| Liu X, Madhankumar AB, Miller PA, et al. (2015) MRI contrast agent for targeting glioma: interleukin-13 labeled liposome encapsulating gadolinium-DTPA. Neuro-Oncology |
| Pang M, Liu X, Madhankumar AB, et al. (2014) RT-40 * THE DOWN-REGULATION OF H-FERRITIN AS AN ADJUVANT THERAPY IN HUMAN GLIOMA Neuro-Oncology. 16: v196-v196 |
| Pang M, Madhankumar AB, Webb B, et al. (2013) Abstract 4436: The down-regulation of ferritin heavy chain as an adjuvant therapy in human glioma. Cancer Research. 73: 4436-4436 |
| Pang M, Liu X, Madhankumar AB, et al. (2012) Abstract 1471: Role of ferritin heavy chain in therapeutic sensitivity of human glioblastoma cells Cancer Research. 72: 1471-1471 |
| Liu X, Madhankumar AB, Slagle-Webb B, et al. (2011) Heavy chain ferritin siRNA delivered by cationic liposomes increases sensitivity of cancer cells to chemotherapeutic agents. Cancer Research. 71: 2240-9 |
| Liu X, Madhankumar AB, Sheehan J, et al. (2011) Abstract 5410: Down regulating heavy chain ferritin gene increasesthe radiation therapeutic efficacy for treatment of glioma Cancer Research. 71: 5410-5410 |